Want to see NVST full AI Analyst Report?
NVST Stock Chart & Stats
$26.33
$0.16(0.61%)
At close: 4:00 PM EDT
$26.33
$0.16(0.61%)
Day’s Range― - ―
52-Week Range$18.77 - $30.42
Previous Close$26.33
Volume1.86M
Average Volume (3M)2.47M
Market Cap
$4.37B
Enterprise Value$5.00K
Total Cash (Recent Filing)$1.13K
Total Debt (Recent Filing)$1.59K
Price to Earnings (P/E)46.1
Beta1.00
Next Earnings
Nov 04, 2026EPS Estimate
0.36Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.59
Shares Outstanding160,617,700
10 Day Avg. Volume2,146,837
30 Day Avg. Volume2,470,277
Financial Highlights & Ratios
PEG Ratio-0.74
Price to Book (P/B)1.17
Price to Sales (P/S)1.34
P/FCF Ratio15.83
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price Target
$30.40Price Target Upside15.46% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering12
EPS Forecast (FY)1.53
Revenue Forecast (FY)$2.88B
Bulls Say, Bears Say
Bulls Say
Broad-based Growth And Margin ExpansionBroad-based demand and operating leverage support durable improvement: Q2 core sales rose 5%, H1 core growth exceeded 7%, while EBITDA margin expanded 230 bps. This can strengthen earnings capacity if adoption and procedure volumes persist.
Resilient Free Cash Flow GenerationPositive operating and free cash flow across periods, including loss years, reduces reliance on accounting earnings. TTM FCF of about $232M and Q2 conversion of 158% provide internal funding for R&D, acquisitions, debt reduction, and shareholder returns.
Product Innovation And Share GainsNew products across endodontics, curing, digital bonding and Spark broaden Envista’s technology platform. Continued innovation can support customer retention, recurring consumables demand and competitive positioning beyond a single product cycle.
Bears Say
China VBP Pricing PressureChina VBP processes expected in 2H26 could drive 10%–15% implant price declines and significant orthodontic compression. Although management expects volume and share recovery, the policy may structurally lower realized pricing and margins in key categories.
Thin And Historically Volatile ProfitabilityDespite recent improvement, profitability remains fragile: the company posted losses in 2023 and 2024, and TTM net margin is only about 3%. Thin earnings leave less buffer against mix shifts, pricing pressure, execution setbacks, or weaker elective demand.
Cyclical And Elective Category ExposureImplants and orthodontics are cyclical and elective, with regional softness already noted in North America versus healthier international markets. This exposure can make procedure volumes, revenue mix and margins more sensitive to macroeconomic conditions than consumables alone.
Envista Holdings News
NVST FAQ
What was Envista Holdings’s price range in the past 12 months?
Envista Holdings lowest stock price was $18.77 and its highest was $30.42 in the past 12 months.
What is Envista Holdings’s market cap?
Envista Holdings’s market cap is $4.37B.
When is Envista Holdings’s upcoming earnings report date?
Envista Holdings’s upcoming earnings report date is Nov 04, 2026 which is in 71 days.
How were Envista Holdings’s earnings last quarter?
Envista Holdings released its earnings results on Aug 05, 2026. The company reported $0.41 earnings per share for the quarter, beating the consensus estimate of $0.335 by $0.075.
Is Envista Holdings overvalued?
According to Wall Street analysts Envista Holdings’s price is currently Undervalued.
Does Envista Holdings pay dividends?
Envista Holdings does not currently pay dividends.
What is Envista Holdings’s EPS estimate?
Envista Holdings’s EPS estimate is 0.36.
How many shares outstanding does Envista Holdings have?
Envista Holdings has 160,617,700 shares outstanding.
What happened to Envista Holdings’s price movement after its last earnings report?
Envista Holdings reported an EPS of $0.41 in its last earnings report, beating expectations of $0.335. Following the earnings report the stock price went down -4.366%.
Which hedge fund is a major shareholder of Envista Holdings?
Currently, no hedge funds are holding shares in NVST
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Envista Holdings Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$30.40 (15.46% Upside)
$30.40 (15.46% Upside)
Blogger Sentiment
Bullish
NVST Sentiment 86%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Decreased
By 977.9K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Negative
Last 7 Days ▼ 1.3%
Last 30 Days ▲ 0.1%
Last 30 Days ▲ 0.1%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
27.38%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-1.19%
Trailing 12-Months
Company Description
Envista Holdings
Envista Holdings Corporation is an enterprise dedicated to the development and distribution of a comprehensive range of dental solutions. These offerings are crucial for the identification, therapeutic intervention, and preventative care of diverse oral health issues, specifically addressing the teeth, gingiva (gums), and their supporting bone structures. The company's principal location is in Brea, California, and it maintains a workforce comprising 12,800 full-time personnel. The firm organizes its business activities into two main divisions: "Specialty Products & Technologies" and "Equipment & Consumables." The Specialty Products & Technologies division concentrates on the creation, fabrication, and promotion of sophisticated dental implant systems, advanced prosthetic devices, and their associated digital treatment software and technological advancements. This segment also provides orthodontic remedies, including bracket systems, clear aligners, and various items for dental laboratories. Conversely, the Equipment & Consumables division is responsible for conceptualizing, producing, and bringing to market a wide array of dental apparatus and vital supplies intended for professional dental clinics. This extensive catalog includes digital imaging instruments, specialized software, and visual or magnification systems; patient treatment units and other essential fixtures for dental practices; complete endodontic kits along with their complementary consumable items; materials and tools for restorative dentistry; rotary cutting tools (burs); impression-making compounds; adhesive agents and dental cements; and products designed for infection control.
NVST Company Deck
NVST Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call reported a strong quarter with broad-based revenue growth, meaningful margin expansion, large EPS and free-cash-flow improvement, a strengthened balance sheet and raised full-year guidance. Operational highlights included robust E&C performance, double-digit Spark growth, successful new product launches, and continued share gains. Headwinds and risks were manageable and largely named and quantified: China VBP-driven price pressure and timing uncertainty, a Q4 billing-day calendar headwind, tariff-related costs, and the end of a small deferral tailwind. Overall, management framed the issues as addressable while emphasizing continued momentum, investment in R&D and commercial initiatives, and confidence in the raised guidance.View all NVST earnings summariesNVST Revenue Breakdown
63.99% Specialty Products & Technologies
36.01% Equipment & Consumables
NVST Stock 12 Month Forecast
Average Price Target
$30.40
▲(15.46% Upside)
Technical Analysis
DENTSPLY SIRONA
―
Disc Medicine
―
Clover Health Investments
―
AbCellera Biologics
―
Bausch + Lomb Corporation
―
Ownership Overview
0.86% Insiders
38.11% Mutual Funds
30.50% Other Institutional Investors
4.93% Public Companies and
Individual Investors